Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001144204-18-056172
Filing Date
2018-10-30
Accepted
2018-10-30 16:40:30
Documents
6
Effectiveness Date
2018-10-30

Document Format Files

Seq Description Document Type Size
1 S-8 tv505663_s8.htm S-8 63568
2 EXHIBIT 5.1 tv505663_ex5-1.htm EX-5.1 7692
3 EXHIBIT 10.1 tv505663_ex10-1.htm EX-10.1 49060
4 EXHIBIT 23.1 tv505663_ex23-1.htm EX-23.1 3042
5 EXHIBIT 23.2 tv505663_ex23-2.htm EX-23.2 3179
6 GRAPHIC tv505663_ex5-1img01.jpg GRAPHIC 9772
  Complete submission text file 0001144204-18-056172.txt   141456
Mailing Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202
Business Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202 (904) 516-5436
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-228056 | Film No.: 181147440
SIC: 2834 Pharmaceutical Preparations